Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study
Author links open overlay panel,
,
,
,
,
,
,
,
,
,
,
,
Highlights
- •
A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients.
- •
Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy.
- •
Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy.
- •
Resolution of fever was 20 h earlier in Standard of care + Homeopathy.
- •
Arsenicum album, Bryonia alba and Phosphorus were the most frequently prescribed medicines.
© 2022 CENTRAL COUNCIL FOR RESEARCH IN HOMOEOPATHY, NEW DELHI , INDIA. Published by Elsevier Ltd.